Melissa Kaufman
-
Phase 3 CELLEBRATE Trial testing regenerative stem cell-based therapy to improve urinary control for women
The Phase 3 CELLEBRATE trial to test a regenerative stem cell-based therapy in treating patients with stress urinary incontinence is continuing to recruit additional subjects after changing its study protocol to include only patients who have already tried surgery. Read MoreMar 11, 2024
-
36 scholars honored at endowed chair investiture ceremony
Vanderbilt Chancellor Daniel Diermeier and Provost and Vice Chancellor for Academic Affairs C. Cybele Raver honored 36 scholars from across the university at an endowed chair investiture ceremony on campus March 30. Read MoreMar 31, 2022
-
Rodes and Patricia Hart establish second chair in Department of Urology
H. Rodes Hart and Patricia Ingram Hart, whose generous gifts continue to advance the mission of Vanderbilt University, have endowed a second chair in urologic surgery. Dr. Melissa R. Kaufman will be the inaugural chair holder. Read MoreApr 16, 2021
-
Urology association honors Kaufman
Melissa Kaufman, M.D., Ph.D., associate professor of Urologic Surgery, received the 2017 Zimskind Award at the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (SUFU) Winter Meeting in Scottsdale, Arizona. Read MoreMar 23, 2017
-
VU study tracks urinary incontinence therapy
More than 15 million women in the United States are impacted by stress urinary incontinence (SUI) at a cost of nearly $20 billion a year to treat. Read MoreApr 2, 2014